User profiles for V. M. Van Deerlin

Vivianna Van Deerlin

Verified email at upenn.edu
Cited by 40798

Analysis of shared heritability in common disorders of the brain

…, JA Sonnen, RA Stern, VM Van Deerlin, LJ Van Eldik… - Science, 2018 - science.org
INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological
comorbidity, inciting debate about their etiologic overlap. However, detailed study of …

Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine

…, CT McMillan, EB Lee, VM Van Deerlin… - Acta …, 2015 - Springer
Frontotemporal lobar degeneration (FTLD) comprises two main classes of neurodegenerative
diseases characterized by neuronal/glial proteinaceous inclusions (ie, proteinopathies) …

Recommended principles and practices for validating clinical molecular pathology tests

L Jennings, VM Van Deerlin… - Archives of pathology & …, 2009 - meridian.allenpress.com
Context.—The use of DNA- and RNA-based tests continues to grow for applications as varied
as inherited disease, infectious disease, cancer, identity testing, human leukocyte antigen …

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

…, JQ Trojanowski, JC Troncoso, VM Van Deerlin… - Nature …, 2011 - nature.com
The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …

[PDF][PDF] Exome sequencing reveals VCP mutations as a cause of familial ALS

…, J Mandrioli, M Benatar, Y Abramzon, VM Van Deerlin… - Neuron, 2010 - cell.com
Using exome sequencing, we identified a p.R191Q amino acid change in the valosin-containing
protein (VCP) gene in an Italian family with autosomal dominantly inherited amyotrophic …

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

…, JQ Trojanowski, VMY Lee, VM Van Deerlin… - Nature, 2010 - nature.com
The causes of amyotrophic lateral sclerosis (ALS), a devastating human neurodegenerative
disease, are poorly understood, although the protein TDP-43 has been suggested to have a …

[HTML][HTML] Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

…, JQ Trojanowski, VM Van Deerlin… - The Lancet …, 2012 - thelancet.com
Background We aimed to accurately estimate the frequency of a hexanucleotide repeat
expansion in C9orf72 that has been associated with a large proportion of cases of amyotrophic …

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

…, JM Ravits, JD Glass, KB Sims, VM Van Deerlin… - Science, 2015 - science.org
Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective
treatment. We report the results of a moderate-scale sequencing study aimed at increasing the …

Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

…, M Grossman, ER Suh, VM Van Deerlin… - Annals of …, 2013 - Wiley Online Library
Objective To see whether the distribution patterns of phosphorylated 43kDa TAR DNA‐binding
protein (pTDP‐43) intraneuronal inclusions in amyotrophic lateral sclerosis (ALS) permit …

TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis

VM Van Deerlin, JB Leverenz, LM Bekris… - The Lancet …, 2008 - thelancet.com
Background TDP-43 is a major component of the ubiquitinated inclusions that characterise
amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with …